Date: 19 April 2024, Friday
Time: 7.30am - 8.30am
Venue: SGH Academia, AC-5-3, Level 5, Singapore
Presenter: Dr Wu Yingying,
Senior Manager, Business Development & Clinical Affairs, Bionano Genomics, Inc.
Brief synopsis:
Learn more about how Optical Genome Mapping can improve diagnosis in constitutional disorders and enhance characterization of hematologic malignancies in clinical settings. Topics covered include multisite evaluation with 100% concordance between OGM and the current gold standard, the combination of karyotyping, fluorescent in-situ hybridization (FISH) and chromosomal microarray (CMA).
Dr Wu Yingying will also share the advantages of OGM through real clinical cases, consisting of reduced hands-on time compared to conventional methods, faster turn-around time, and lower cost compared to the combination of standard methods.